Literature DB >> 26840616

Long-Term Extracorporeal Membrane Oxygenation as Bridging Strategies to Lung Transplantation in Rapidly Devastating Isolated Langerhans Cell Histiocytosis.

Oliviero Sacco1, Andrea Moscatelli2, Massimo Conte3, Chiara Grasso2, Gian Michele Magnano4, Angela Rita Sementa5, Alberto Martelli6, Giovanni A Rossi1.   

Abstract

Isolated pulmonary involvement in pediatric Langerhans cell histiocytosis (LCH) is extremely rare. While the multisystem-LCH course varies from spontaneous remission to rapid deterioration with lethal outcome, single system involvement is generally associated with favorable prognosis. A child with isolated pulmonary LCH had an extremely rapid progression leading to respiratory failure, despite treatment with prednisone and vinblastine. Since lung hyperinflation and cystic degeneration contraindicated conventional mechanical ventilation, extracorporeal membrane oxygenation (ECMO) was chosen for 50 days as a bridge to lung transplantation. The mechanisms involved in disease progression and the usefulness of long-term ECMO are discussed.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  critical care medicine; histiocytosis; transplantation

Mesh:

Substances:

Year:  2016        PMID: 26840616     DOI: 10.1002/pbc.25912

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  2 in total

Review 1.  Paediatric pulmonary Langerhans cell histiocytosis.

Authors:  Mhairi Barclay; Rebecca Devaney; Jayesh M Bhatt
Journal:  Breathe (Sheff)       Date:  2020-06

2.  Management of severe pulmonary Langerhans cell histiocytosis in children.

Authors:  Olive S Eckstein; Jed G Nuchtern; George B Mallory; R Paul Guillerman; Matthew A Musick; Mhairi Barclay; Jayesh M Bhatt; Patrick Davies; Richard G Grundy; Alice Martin; Tom Hilliard; Stephen P Lowis; Susan Picton; Vasanta Nanduri; Johannes Visser; Carl E Allen; Kenneth L McClain
Journal:  Pediatr Pulmonol       Date:  2020-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.